Trimethroprim and sulfalene therapy of Plasmodium vivax.
D000814:Aniline Compounds / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D003622:Dapsone / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D010966:Plasmodium vivax / Q000187:drug effects*; D011719:Pyrazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D013412:Sulfadimethoxine / Q000627:therapeutic use
D000814:Aniline Compounds; D005493:Folic Acid Antagonists; D011719:Pyrazines; D011743:Pyrimidines; D013412:Sulfadimethoxine; D003622:Dapsone